ArticleFrontiers in medicine2022

Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences.

Yuanming Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.